We are live on ! Find out more
RCMNY

Rubric Capital Management (New York) Portfolio holdings

AUM $9.44B
1-Year Est. Return 68.42%
This Fund
S&P 500
This Quarter Est. Return
+8.45%
1 Year Est. Return
+68.42%
3 Year Est. Return
+212.09%
5 Year Est. Return
+270.59%
10 Year Est. Return
–
AUM
$8.36B
AUM Growth
-$501M
Cap. Flow
-$840M
Cap. Flow %
-10.05%
Top 10 Hldgs %
55.3%
Holding
88
New
16
Increased
20
Reduced
17
Closed
12

Top Buys

Rank Stock Value
1
VST icon
Vistra
VST
+$364M
2
CEG icon
Constellation Energy
CEG
+$243M
3
VTRS icon
Viatris
VTRS
+$109M
4
AKAM icon
Akamai
AKAM
+$98.7M
5
PRMB
Primo Brands
PRMB
+$67.1M

Top Sells

Rank Stock Value
1
ROIV icon
Roivant Sciences
ROIV
+$217M
2
BAX icon
Baxter International
BAX
+$86M
3
TEVA icon
Teva Pharmaceuticals
TEVA
+$81.2M
4
ARQT icon
Arcutis Biotherapeutics
ARQT
+$63.4M
5
COLL icon
Collegium Pharmaceutical
COLL
+$55.6M

Sector Composition

Rank Sector Weight
1 Healthcare 33.3%
2 Utilities 26.27%
3 Industrials 14.79%
4 Energy 5.36%
5 Financials 4.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CXW icon
51
CoreCivic
CXW
$3.32B
$37.5M 0.45%
1,961,446
– –
PRTA icon
52
Prothena Corp
PRTA
$475M
$35.1M 0.42%
3,677,331
+2,136,958
+139% +$21.8M
GPK icon
53
Graphic Packaging
GPK
$3.46B
$30.1M 0.36%
+2,000,000
New +$32.9M
NFE icon
54
New Fortress Energy
NFE
$94M
$27M 0.32%
23,701,399
-1,065,688
-4% -$1.57M
TSAT icon
55
Telesat
TSAT
$934M
$24.6M 0.29%
843,781
– –
DAR icon
56
Darling Ingredients
DAR
$10B
$24.5M 0.29%
+680,827
New +$23M
XPER icon
57
Xperi
XPER
$321M
$24.3M 0.29%
4,143,744
– –
INDV icon
58
Indivior Pharmaceuticals
INDV
$4.57B
$17.9M 0.21%
498,527
-632,434
-56% -$19.3M
TH icon
59
Target Hospitality
TH
$1.61B
$17.5M 0.21%
2,189,456
– –
EPC icon
60
Edgewell Personal Care
EPC
$1.32B
$17.2M 0.21%
+1,007,071
New +$18.6M
CPRI icon
61
Capri Holdings
CPRI
$1.77B
$16.5M 0.2%
+675,000
New +$15.6M
GIL icon
62
Gildan
GIL
$10.6B
$16M 0.19%
256,398
+172,146
+204% +$10.2M
SW
63
Smurfit Westrock
SW
$25.8B
$15.5M 0.19%
+400,000
New +$15.3M
CRI icon
64
Carter's
CRI
$1.43B
$14.9M 0.18%
+460,000
New +$14.4M
LILA icon
65
Liberty Latin America Class A
LILA
$1.69B
$14.4M 0.17%
2,860,192
+294,400
+11% +$1.63M
EMBC icon
66
Embecta
EMBC
$269M
$12.3M 0.15%
1,037,416
– –
ACHC icon
67
Acadia Healthcare
ACHC
$2.95B
$12.1M 0.14%
850,000
-250,000
-23% -$4.73M
SEG
68
Seaport Entertainment Group
SEG
$373M
$11.2M 0.13%
568,530
– –
STUB
69
StubHub Holdings
STUB
$3.21B
$10.6M 0.13%
+784,854
New +$12.3M
ABUS icon
70
Arbutus Biopharma
ABUS
$907M
$7.58M 0.09%
1,575,376
– –
MREO
71
Mereo BioPharma
MREO
$48.3M
$6.38M 0.08%
15,307,347
– –
HELE icon
72
Helen of Troy
HELE
$696M
$5.46M 0.07%
+256,937
New +$5.24M
TXMD icon
73
TherapeuticsMD
TXMD
$24.1M
$1.94M 0.02%
1,192,191
– –
MYPS icon
74
PLAYSTUDIOS Inc
MYPS
$72.1M
$1.76M 0.02%
2,697,384
– –
EDSA icon
75
Edesa Biotech
EDSA
$51.1M
$976K 0.01%
687,500
– –
1 2
3
4

Similar funds

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
AC
Allstate Corporation Northbrook, Illinois $9.35B AUM 16.13% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.34B AUM 12.2% 1-Year Est. Return
WPL
WINDACRE PARTNERSHIP LLC Houston, Texas $9.34B AUM 17.41% 1-Year Est. Return
LAMI
Longview Asset Management (Illinois) Chicago, Illinois $9.56B AUM 25.94% 1-Year Est. Return
CCMT
CMT Capital Markets Trading Frankfurt, Germany $9.56B AUM 21.2% 1-Year Est. Return

Rubric Capital Management (New York)'s Q4 2025 Portfolio in Review

As of Q4 2025, Rubric Capital Management (New York) held 88 positions worth $8.36B, down 5.7% from $8.86B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Rubric Capital Management (New York) withdrew a net $840M in Q4 2025, closing 12 positions and reducing 17 holdings. Its most notable exit was Baxter International, an estimated $86M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 31% a quarter earlier, followed by Utilities and Industrials.

Against the trend, Rubric Capital Management (New York) opened a new position in Vistra worth $323M.

  • Rubric Capital Management (New York)'s largest Q4 2025 buy was Vistra: 2,000,000 shares worth $323M.
  • Rubric Capital Management (New York) added most to Viatris in Q4 2025, an estimated $109M increase.
  • Rubric Capital Management (New York)'s biggest Q4 2025 reduction was Roivant Sciences, cutting an estimated $217M.
  • Rubric Capital Management (New York) fully exited Baxter International in Q4 2025, selling an estimated $86M.
  • Rubric Capital Management (New York)'s ten largest holdings make up 55% of its $8.36B portfolio in Q4 2025.
  • Rubric Capital Management (New York) opened 16 new positions and closed 12 in Q4 2025.
  • Rubric Capital Management (New York)'s portfolio value fell 5.7% quarter-over-quarter to $8.36B.

Based on Rubric Capital Management (New York)'s 13F filing for Q4 2025, filed 13 Feb 2026.